Cabozantinib plus nivolumab and ipilimumab in renal-cell carcinoma - The authors reply Correspondence


Authors: Choueiri, T. K.; Wang, F.; Motzer, R. J.
Title: Cabozantinib plus nivolumab and ipilimumab in renal-cell carcinoma - The authors reply
Keywords: ipilimumab; pathology; renal cell carcinoma; kidney neoplasms; kidney tumor; carcinoma, renal cell; cabozantinib; nivolumab; humans; human
Journal Title: New England Journal of Medicine
Volume: 389
Issue: 5
ISSN: 0028-4793
Publisher: Massachusetts Medical Society  
Date Published: 2023-08-03
Start Page: 477
End Page: 478
Language: English
PUBMED: 37530836
PROVIDER: scopus
DOI: 10.1056/NEJMc2306786
DOI/URL:
Notes: Letter -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Robert Motzer
    1243 Motzer